Clinical Trial Update: Treatment of Adult-Onset Immunodeficiency With Bortezomib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating bortezomib for the treatment of adult-onset immunodeficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adult-onset Immunodeficiency

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Mahidol University | Conditions: Adult-onset Immunodeficiency | Phase 2 | Status: UNKNOWN